Previous close | 5.80 |
Open | N/A |
Bid | 5.40 |
Ask | 6.80 |
Strike | 900.00 |
Expiry date | 2026-01-16 |
Day's range | 5.80 - 5.80 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.